About: Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2007 (uk) im Oktober 2007 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 2007 (ast) scientific article published on 01 October 2007 (en)
publication date	wds:Q61819220-5D9999D7-6FC6-4065-B69D-0DBE43B91DE8
publication date	2007-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q61819220-DCA3F16E-9F7B-4EEE-AB34-FA669CA599D7
language of work or name	English
author name string	wds:Q61819220-00A30999-65A5-448F-BFEC-7575BA3520BB wds:Q61819220-1259DB7F-AF73-4553-B13D-61B89AC0EC43 wds:Q61819220-1D82B2D7-C6F9-4CE5-8BFC-D18699CC32F6 wds:Q61819220-2DE25721-0702-43DE-BEDC-5F5ED9DC7B63 wds:Q61819220-39769B83-CECA-40C5-9491-E315B7275CD5 wds:Q61819220-3C424FE0-3FCC-4D44-8FB3-E8C84EBAC27C wds:Q61819220-461428A5-28D2-4690-9DD5-E5CC4AA48E0F wds:Q61819220-6B2BAC96-6D60-46AA-B878-48EE99BF14EC wds:Q61819220-6EC3B756-64EF-49D8-B47A-BED6B17197B6 wds:Q61819220-752A7595-F7B7-4D4A-8E35-C02ED99B3635 wds:Q61819220-821AFD18-CCC1-498D-AC6C-1CF69B6BDC6B wds:Q61819220-87155CE4-B2F7-46C2-B8E3-8D1B3CC221E6 wds:Q61819220-A5D1F9D4-CA31-42A4-8464-A73AA9F1EB43 wds:Q61819220-C412319A-F4D5-4536-BC08-5120150E8216 wds:Q61819220-CB7A26A9-F505-421F-87CD-240CA912211E wds:Q61819220-E0EEA368-C82E-4BBD-BC95-4D4E6AEDCBD4 wds:Q61819220-E5EE2B57-3689-4822-A98E-E63312189A8D
author name string	Kate Hall David Chao Martin Gore Eleni Timotheadou Tim Eisen Michelle L Harrison Mark DeWitte Robert Corringham Kim Edmonds Kellie Charles Chooi Lee Ningfeng F Li Roger Ahern Eva Obermueller Susan Hoare D Mike King Nick R Maisey
rdfs:label	Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose (en) Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose (nl)
skos:prefLabel	Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose (en) Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose (nl)
name	Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose (en) Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose (nl)
author	wds:Q61819220-20333D88-84C9-47F6-91A6-54E80703A84E
author	Fran Balkwill
title	wds:Q61819220-2A4450FA-A4A6-40F7-9E4B-FE11DACCA4F1
title	Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose (en)
page(s)	wds:Q61819220-A59735F7-6FEB-41A2-8B26-C0BF592BDEA7
page(s)	4542-4549
instance of	wds:Q61819220-1E26BDF4-D23A-4BB4-A14E-2168009DEF70
instance of	scholarly article
main subject	wds:Q61819220-360B4DB0-0664-4F22-970D-B86010C1A736 wds:Q61819220-78476411-004B-402A-B86C-1DB3BB2A77FD
main subject	renal cell carcinoma phase II clinical trial
PubMed ID	wds:Q61819220-8ACAF30D-1703-4F33-AE53-8E9E6053F666
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17925549
PubMed ID	17925549
published in	wds:Q61819220-B5CE6635-5F20-4DC5-8655-A51F12357746
published in	Journal of Clinical Oncology
issue	wds:Q61819220-6F9B9892-4FE8-4E86-A51B-3B4B0D565280
volume	wds:Q61819220-86E999E3-21CD-4978-B7F2-AB9E2D2BEA09
issue	29
volume	25
DOI	wds:Q61819220-A9B3BB2A-1100-4134-9348-9A3C06F0C7BF
DOI	http://dx.doi.org/10.1200/JCO.2007.11.2136
DOI	10.1200/JCO.2007.11.2136
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61819220
is cites work of	Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer Tumour necrosis factor and cancer TNF signaling drives myeloid-derived suppressor cell accumulation Tumor necrosis factor and cancer, buddies or foes? Interleukin-6 as a therapeutic target in human ovarian cancer Cancer-related inflammation Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis Cytokines, inflammation and colon cancer Molecular basis for defining the pineal gland and pinealocytes as targets for tumor necrosis factor. Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients. Claudin 1 mediates TNFα-induced gene expression and cell migration in human lung carcinoma cells Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Lipid Signaling in Tumorigenesis The tumor microenvironment and its role in promoting tumor growth Molecular mechanisms underlying chronic inflammation-associated cancers Cytokine patterns in patients with cancer: a systematic review. Inflammation and cancer: advances and new agents Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array. Cancer and inflammation: implications for pharmacology and therapeutics Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1beta-dependent stabilization of Snail in tumor cells TNF receptors: signaling pathways and contribution to renal dysfunction The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software